Verrica Pharmaceuticals's total assets for Q1 2025 were $42.18M, a decrease of -22.09% from the previous quarter. VRCA total liabilities were $60.75M for the fiscal quarter, a -5.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.